Imbruvica (ibrutinib tablets, capsules, and oral suspension) — Cigna

Initial criteria

• Patient is age ≥ 18 years
• Patient meets ONE of the following: i) continuing therapy with Imbruvica AND has tried at least one systemic regimen OR not a candidate for a chemotherapy regimen; OR ii) Imbruvica is used in combination with rituximab prior to induction therapy

Approval duration

1 year